DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ACIPHEX
02 1AEMCOLO
03 1ESOMEPRAZOLE MAGNESIUM
04 11PANTOPRAZOLE SODIUM
05 1PROTONIX
06 8RABEPRAZOLE SODIUM
01 120973
02 120987
03 176822
04 176885
05 177056
06 177058
07 177619
08 178964
09 190074
10 190797
11 190901
12 190970
13 191231
14 1200821
15 1202038
16 1202052
17 1202376
18 1204179
19 1204237
20 1205761
21 1208644
22 1210910
23 1211571
01 22No
02 1Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 211571
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 90797
Country : US
Patented : No
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 208644
Country : US
Patented : No
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204179
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 91231
Country : US
Patented : No
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 205761
Country : US
Patented : No
Drug : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 202038
Country : US
Patented : No
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 78964
Country : US
Patented : No
Drug : PROTONIX
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 20987
Country : US
Patented : No
Drug : RABEPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 76885
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
